Results 11 to 20 of about 1,293,835 (325)

Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal [PDF]

open access: yes, 2020
Funding This study is co-funded by Fundação para a Ciência e a Tecnologia and Agência de Investigação Clínica e Inovação Biomédica [grant number 234_596874175] on behalf of the Research 4 COVID-19 call. This work is also a result of the GenomePT project [
Portuguese network for SARS-CoV-2 genomics
core   +1 more source

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

open access: yesNew England Journal of Medicine, 2020
Aerosol and Surface Stability of SARS-CoV-2 In this research letter, investigators report on the stability of SARS-CoV-2 and SARS-CoV-1 under experimental conditions.
N. van Doremalen   +12 more
semanticscholar   +1 more source

Genomic Sequencing and Analysis of a Novel Human Cowpox Virus With Mosaic Sequences From North America and Old World Orthopoxvirus

open access: yesFrontiers in Microbiology, 2022
Orthopoxviruses (OPXVs) not only infect their natural hosts, but some OPXVs can also cause disease in humans. Previously, we partially characterized an OPXV isolated from an 18-year-old male living in Northern Norway.
Diana Diaz-Cánova   +4 more
doaj   +1 more source

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

open access: yesNew England Journal of Medicine, 2020
Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion ...
L. Baden   +36 more
semanticscholar   +1 more source

The design of Indonesian SARS‐CoV‐2 primers based on phylogenomic analysis of the SARS‐CoV‐2 clades

open access: yesIndonesian Journal of Biotechnology, 2022
Molecular detection needs to be augmented for COVID‐19 detection in Indonesia using the PCR method with primer‐based gene analysis. This is necessary because the RNA of the SARS‐CoV‐2 virus, the causative infectious agent of the pandemic, has been ...
Tsania Taskia Nabila   +3 more
doaj   +1 more source

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

open access: yesScience, 2020
How SARS-CoV-2 binds to human cells Scientists are racing to learn the secrets of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), which is the cause of the pandemic disease COVID-19. The first step in viral entry is the binding of the viral
R. Yan   +5 more
semanticscholar   +1 more source

SARS‐CoV‐2 and hypertension

open access: yesPhysiological Reports, 2021
The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is
Briyanth Ravichandran   +5 more
doaj   +1 more source

The proximal origin of SARS-CoV-2

open access: yesNature Medicine, 2020
SARS-CoV-2 is the seventh coronavirus known to infect humans; SARSCoV, MERS-CoV and SARS-CoV-2 can cause severe disease, whereas HKU1, NL63, OC43 and 229E are associated with mild symptoms6. Here we review what can be deduced about the origin of SARS-CoV-
Kristian G. Andersen   +5 more
semanticscholar   +1 more source

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

open access: yesInternational Journal of Antimicrobial Agents, 2020
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public ...
Chih-Cheng Lai   +4 more
semanticscholar   +1 more source

2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission. [PDF]

open access: yes, 2020
With the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in coronavirus disease 2019 (COVID-19), corporate entities, federal, state, county, and city governments, universities, school districts, places of worship,
Coil, David A   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy